Daniel E Jonas

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
    Daniel E Jonas
    University of North Carolina at Chapel Hill, Department of Medicine, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Ann Intern Med 157:645-54. 2012
  2. ncbi Identifying priorities for patient-centered outcomes research for serious mental illness
    Daniel E Jonas
    Department of Medicine, University of North Carolina atChapel Hill, 5039 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Psychiatr Serv 63:1125-30. 2012
  3. ncbi Chapter 11: challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators
    Daniel E Jonas
    Department of Medicine, Cecil G Sheps Center for Health Services Research, and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Gen Intern Med 27:S83-93. 2012
  4. ncbi Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study
    Daniel E Jonas
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Med Decis Making 28:56-65. 2008
  5. ncbi Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
    Health Econ 19:1193-211. 2010
  6. ncbi Patient time requirements for anticoagulation therapy with warfarin
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, USA
    Med Decis Making 30:206-16. 2010
  7. ncbi Patient time requirements for screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 102:2401-10. 2007
  8. ncbi Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Interv Aging 3:211-25. 2008
  9. ncbi Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials
    Gary N Asher
    Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Altern Complement Med 16:1097-108. 2010
  10. ncbi Quality of reporting on randomised controlled trials of auriculotherapy for pain
    Gary N Asher
    Department of Family Medicine, University of North Carolina, Chapel Hill, NC 27599 7595, USA
    Acupunct Med 29:122-6. 2011

Collaborators

Detail Information

Publications15

  1. ncbi Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
    Daniel E Jonas
    University of North Carolina at Chapel Hill, Department of Medicine, 5034 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Ann Intern Med 157:645-54. 2012
    ..Alcohol misuse, which includes the full spectrum from risky drinking to alcohol dependence, is a leading cause of preventable death in the United States...
  2. ncbi Identifying priorities for patient-centered outcomes research for serious mental illness
    Daniel E Jonas
    Department of Medicine, University of North Carolina atChapel Hill, 5039 Old Clinic Building, CB 7110, Chapel Hill, NC 27599, USA
    Psychiatr Serv 63:1125-30. 2012
    ..The purpose of this project was to engage a diverse group of stakeholders (N=38) to help establish priorities to guide patient-centered outcomes research (PCOR) in serious mental illness...
  3. ncbi Chapter 11: challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators
    Daniel E Jonas
    Department of Medicine, Cecil G Sheps Center for Health Services Research, and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC 27599, USA
    J Gen Intern Med 27:S83-93. 2012
    ..In addition, reviewers should note whether appropriate adjustments for multiple comparisons were used...
  4. ncbi Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study
    Daniel E Jonas
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Med Decis Making 28:56-65. 2008
    ..The authors sought to estimate the amount and value of patient time required for screening colonoscopy...
  5. ncbi Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
    Health Econ 19:1193-211. 2010
    ..The screening colonoscopy process requires a considerable amount of time and some discomfort for patients...
  6. ncbi Patient time requirements for anticoagulation therapy with warfarin
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, USA
    Med Decis Making 30:206-16. 2010
    ..Most patients receiving warfarin are managed in outpatient office settings or anticoagulation clinics that require frequent visits for monitoring...
  7. ncbi Patient time requirements for screening colonoscopy
    Daniel E Jonas
    Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 102:2401-10. 2007
    ..To measure the amount of time patients spend in the screening colonoscopy process...
  8. ncbi Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis
    Richard A Hansen
    School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Clin Interv Aging 3:211-25. 2008
    ..63 and 1.42, respectively). Indirect comparisons also favored donepezil over galantamine with regard to behavior. Across trials, the incidence of adverse events was generally lowest for donepezil and highest for rivastigmine...
  9. ncbi Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials
    Gary N Asher
    Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Altern Complement Med 16:1097-108. 2010
    ..Our aim was to conduct a systematic review and meta-analysis of studies evaluating auriculotherapy for pain management...
  10. ncbi Quality of reporting on randomised controlled trials of auriculotherapy for pain
    Gary N Asher
    Department of Family Medicine, University of North Carolina, Chapel Hill, NC 27599 7595, USA
    Acupunct Med 29:122-6. 2011
    ....
  11. ncbi Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis
    Rishi J Desai
    Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA
    Ann Pharmacother 46:1491-505. 2012
    ..Very little information is available on comparative discontinuation rates of the biologics...
  12. ncbi Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care
    Tejinder K Rakhra-Burris
    UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7361, USA
    Pharmacogenomics 11:13-21. 2010
    ..IPIT Investigators are actively incorporating a pharmacogenomics curriculum into existing teaching programs at all levels...
  13. ncbi Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis
    Daniel J Crespin
    Department of Health Policy and Management, University of North Carolina, Chapel Hill, NC, USA
    Value Health 14:483-91. 2011
    ..In 2011, clopidogrel will lose its patent protection and likely will be substantially less expensive than ticagrelor...
  14. ncbi How much time do adults spend on health-related self-care? Results from the American time use survey
    Daniel E Jonas
    University of North Carolina, Chapel Hill, Department of Medicine, Division of General Medicine, Chapel Hill, NC 27599, USA
    J Am Board Fam Med 24:380-90. 2011
    ..Objective: The aim of this study was to describe how much time American adults reported spending on health-related self-care (eg, taking insulin, dressing a wound)...
  15. ncbi Genetic and clinical factors relating to warfarin dosing
    Daniel E Jonas
    University of North Carolina, Chapel Hill, 5039 Old Clinic Building, Campus Box 7110, Chapel Hill, NC 27599, USA
    Trends Pharmacol Sci 30:375-86. 2009
    ..Whether genotype-guided dosing is clinically beneficial remains unclear, but studies are currently underway that will help to determine this...